Initial CA72-4, CEA, and CA19-9 levels as tumor markers for esophageal carcinoma were present in 95% of ESCC patients, while initial CYFRA21-1 and SCC levels were known in 91% of patients. This evidence concerns the gene SERPINB3 and carcinoma of esophagus.